Fmr LLC Glaukos Corp Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Glaukos Corp stock. As of the latest transaction made, Fmr LLC holds 6,787,919 shares of GKOS stock, worth $857 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,787,919

Previous 7,356,921 7.73%

Holding current value

$857 Million

Previous $694 Million 15.81%

% of portfolio

0.05%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$89.48 - $118.35 $50.9 Million - $67.3 Million	-569,002 Reduced 7.73%	6,787,919 $803 Million
Q1 2024 May 13, 2024	BUY	$76.4 - $96.33 $117 Million - $148 Million	1,537,811 Added 26.43%	7,356,921 $694 Million
Q4 2023 Feb 13, 2024	BUY	$59.53 - $85.11 $139 Million - $199 Million	2,336,733 Added 67.1%	5,819,110 $463 Million
Q3 2023 Nov 13, 2023	BUY	$69.23 - $79.09 $241 Million - $275 Million	3,479,548 Added 122995.69%	3,482,377 $262 Million
Q2 2023 Aug 11, 2023	SELL	$45.44 - $71.21 $5,907 - $9,257	-130 Reduced 4.39%	2,829 $201,000
Q1 2023 May 11, 2023	BUY	$43.88 - $52.48 $29,970 - $35,843	683 Added 30.01%	2,959 $148,000
Q4 2022 Feb 13, 2023	SELL	$40.82 - $57.75 $25,145 - $35,574	-616 Reduced 21.3%	2,276 $99,000
Q3 2022 Nov 10, 2022	BUY	$46.84 - $58.49 $15,082 - $18,833	322 Added 12.53%	2,892 $155,000
Q2 2022 Aug 12, 2022	SELL	$34.86 - $63.77 $41,622 - $76,141	-1,194 Reduced 31.72%	2,570 $117,000
Q1 2022 May 13, 2022	BUY	$44.33 - $57.82 $61,352 - $80,022	1,384 Added 58.15%	3,764 $217,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $331,905 - $469,711	-8,242 Reduced 77.59%	2,380 $106,000
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $13.5 Million - $23.9 Million	-283,880 Reduced 96.39%	10,622 $511,000
Q2 2021 Aug 13, 2021	BUY	$73.06 - $97.7 $21.5 Million - $28.8 Million	294,502 New	294,502 $25 Million

Others Institutions Holding GKOS

# of Institutions

303

Shares Held

47M

Call Options Held

75.3K

Put Options Held

157K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.01B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account